23AndMe, Inc.
23AndMe, Inc. holds FDA 510(k) medical device clearances, first cleared 2017, most recent 2023.
Top product codes for 23AndMe, Inc.
Recent clearances by 23AndMe, Inc.
- K223597 — 23andMe® Personal Genome Service® (PGS®) Genetic Health Risk Report for BRCA1/BRCA2 (Selected Variants)
- K221885 — 23andMe Personal Genome Service (PGS) Pharmacogenetic Reports
- K211499 — 23andMe PGS Genetic Risk Report for Hereditary Prostate Cancer (HOXB13-Related)
- K193492 — 23andMe Personal Genome Service (PGS) Pharmacogenetic Reports
- K182784 — MUTYH-Associated Polyposis (MAP)
- DEN180028 — 23andMe Personal Genome Service (PGS) Pharmacogenetic Reports
- DEN170046 — 23andMe PGS Genetic Health Risk Report for BRCA1/BRCA2 (Selected Variants)
- DEN160026 — 23andMe Personal Genome Service (PGS) Genetic Health Risk Test for Hereditary Thrombophilia
Data sourced from openFDA. This site is unofficial and independent of the FDA.